PPH

PPH
About VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
About VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
LLY | Eli Lilly and Company | 18.68% | 234.86K | $240.03M |
NVS | Novartis AG | 11.39% | 884.30K | $146.36M |
MRK | Merck & Co., Inc. | 9.53% | 1.03M | $122.46M |
MCK | McKesson Corporation | 4.90% | 64.58K | $62.93M |
GSK | GSK plc | 4.90% | 1.08M | $62.98M |
BMY | Bristol-Myers Squibb Company | 4.87% | 1.03M | $62.65M |
JNJ | Johnson & Johnson | 4.82% | 254.21K | $61.89M |
PFE | Pfizer Inc. | 4.77% | 2.26M | $61.33M |
AZN | AstraZeneca PLC | 4.54% | 285.80K | $58.30M |
NVO | Novo Nordisk A/S | 4.50% | 1.54M | $57.89M |
SNY | Sanofi | 4.09% | 1.09M | $52.60M |
ABBV | AbbVie Inc. | 4.08% | 233.16K | $52.39M |
COR | Cencora, Inc. | 4.07% | 142.50K | $52.25M |
ZTS | Zoetis Inc. | 3.39% | 335.99K | $43.60M |
HLN | Haleon plc | 3.02% | 3.60M | $38.76M |
TAK | Takeda Pharmaceutical Company Limited | 2.90% | 2.01M | $37.28M |
TEVA | Teva Pharmaceutical Industries Limited | 2.66% | 1.01M | $34.21M |
VTRS | Viatris Inc. | 0.86% | 728.22K | $11.11M |
JAZZ | Jazz Pharmaceuticals plc | 0.66% | 45.19K | $8.54M |
ELAN | Elanco Animal Health Incorporated | 0.47% | 230.99K | $6.05M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Holdings (Top 20)
LLY
Eli Lilly and Company
NVS
Novartis AG
MRK
Merck & Co., Inc.
MCK
McKesson Corporation
GSK
GSK plc
BMY
Bristol-Myers Squibb Company
JNJ
Johnson & Johnson
PFE
Pfizer Inc.
AZN
AstraZeneca PLC
NVO
Novo Nordisk A/S
SNY
Sanofi
ABBV
AbbVie Inc.
COR
Cencora, Inc.
ZTS
Zoetis Inc.
HLN
Haleon plc
TAK
Takeda Pharmaceutical Company Limited
TEVA
Teva Pharmaceutical Industries Limited
VTRS
Viatris Inc.
JAZZ
Jazz Pharmaceuticals plc
ELAN
Elanco Animal Health Incorporated
